A rapidly spreading and increasingly drug-resistant fungus, *candida auris*, is prompting urgent warnings from global health officials as itS now been detected in 61 countries. The fungus, nicknamed “white spot disease,” poses a heightened threat to individuals with compromised immune systems and carries a mortality rate exceeding 50% in those infected. This emerging public health challenge underscores the growing dangers of antifungal resistance,a trend the World Health Institution has identified as a priority area for action [[WHO link on antimicrobial resistance]].
December 30, 2025 at 9:53 PM (Doha time)
Global health experts are warning of a growing threat from a potentially deadly fungus that has now been detected in 61 countries and is demonstrating increasing resistance to medications. The fungus, known as Candida auris, is also exhibiting a heightened ability to cause illness, with a mortality rate exceeding 50% among those infected. This rise in drug-resistant fungal infections is a significant concern for public health, particularly for individuals with weakened immune systems.
The spread of Candida auris, sometimes referred to as “white spot disease,” is occurring alongside a broader trend: fungal infections globally affect approximately 6.5 million people annually, resulting in more than half of those infected dying – even with available treatments.
Candida auris is a type of invasive yeast that can cause severe and often fatal infections, especially in people with compromised immune systems. First identified in 2009 in a patient’s ear canal in Japan, the fungus rapidly spread to dozens of countries, including India, where it was declared a major public health threat in 2014.
Recent scientific reviews reveal a unique combination of characteristics that contribute to the fungus’s rapid dissemination. It has now been reported in at least 61 countries across six continents.
One key feature is the fungus’s ability to quickly switch between a typical yeast form and a filamentous growth pattern, which facilitates its spread. Additionally, Candida auris possesses specialized proteins in its cell wall that allow it to adhere to human skin “like an adhesive,” enabling colonization. This skin colonization, according to a study published in Microbiology and Molecular Biology Reviews, is a significant clinical concern, as it can turn infected patients into carriers within hospital settings, expanding the reach of the infection.
The danger of Candida auris extends beyond its rapid spread to include the development of drug resistance through sophisticated mechanisms. The fungus is equipped with “efflux pumps” on its cell membrane that expel antifungal drugs before they can take effect. It can also form sticky layers, known as biofilms, on various surfaces, protecting it and hindering drug penetration. Researchers continue to investigate whether the fungus possesses additional methods of resisting treatment.
